(19)

(11)

EP 4 505 433 A2

(12)

(88) Date of publication A3: 09.11.2023 (43) Date of publication: 12.02.2025 Bulletin 2025/07 (21) Application number: 23785522.6 (22) Date of filing: 08.03.2023

(51) International Patent Classification (IPC):  G07F 17/32(2006.01) G06N 20/00(2019.01) A63F 13/00(2014.01) (52) Cooperative Patent Classification (CPC): G07F 17/323; G07F 17/3288 (86) International application number: PCT/US2023/063915 (87) International publication number: WO 2023/196722 (12.10.2023 Gazette 2023/41)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 04.04.2022 US 202217712298 (71) Applicant: ADRENALINEIP Washington, DC 20007 (US)	(72) Inventors: HUKE, Casey, Alexander Washington, DC 20007 (US) CRONIN, John Jericho, VT 05465 (US) D'ANDREA, Michael Burlington, VT 05408 (US) (74) Representative: Araujo, Daniel  Ingenias Creaciones Signos e Invenciones S.L. Avda Diagonal 514 Planta 1, Puerta 4 08006 Barcelona 08006 Barcelona (ES)